SCHEMBL20042656

SCHEMBL20042656

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)c1cc(Cl)cc(C#N)c1)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPK1 P28482 1/20 0.36
GPR6 P46095 2/20 0.35
P2RX7 Q99572 2/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20043028 0.90 KDM4E (0.40) KDM4EHPGDTSHRCASP1CASP7
SCHEMBL20042689 0.90 P2RX7 (0.39) CASP1CASP7HSD17B10P2RX7TP53
SCHEMBL20042713 0.88 GRM5 (0.45) KDM4EHPGDTSHRCASP1CASP7
SCHEMBL20042854 0.87 GRM5 (0.42) KDM4EHPGDTSHRCASP1CASP7
SCHEMBL20042721 0.85 GRM5 (0.47) MEN1KMT2AP2RX7L3MBTL1GRM5
SCHEMBL20042863 0.85 GRM5 (0.42) P2RX7TP53THRBTDP1GRM5
SCHEMBL20042728 0.85 MEN1 (0.42) MEN1KMT2AALDH1A1GPR6L3MBTL1
SCHEMBL20042821 0.82 MEN1 (0.41) KDM4EHPGDTSHRCASP1CASP7
SCHEMBL20042733 0.82 MEN1 (0.41) KDM4EHPGDTSHRCASP1CASP7
SCHEMBL20042702 0.82 P2RX7 (0.49) TSHRHSD17B10MEN1KMT2AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed